PRL 3 Antilichaam

Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis. May be involved in the progression of cardiac hypertrophy by inhibiting intracellular calcium mobilization in response to angiotensin II.

11156

O75365

NP_116000

Human, Mouse

PRL-3 antibody was raised against a peptide sequence around aa. 161-166 (K-D-P-H-T) derived from Human PTP4A3.

Unconjugated

Primary Antibodies

Apoptosis, Cancer

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

22 kDa

This antibody detects transfected PRL-3 protein.

Western Blot: 1:500~1:1000

PTP4A3

Protein tyrosine phosphatase type IVA, member 3

Homo sapiens

Matter W. F. et. al. Biochem. Biophys. Res. Commun. 283:1061-1068 (2001) Wang J. et. al. J. Biol. Chem. 277:46659-46668 (2002)

PRL3, PRL-3, PRL-R, HDACL1, CDA07, protein tyrosine phosphatase type IVA, PRL3, PTP4A3

WB

14589856

Liquid